New cell therapy takes on deadly transplant complication
Disease control
Terminated
This study tested a new treatment called DSC (donor stem cells) compared to the best available standard therapy for people with severe graft-versus-host disease (GVHD) after a stem cell transplant. GVHD happens when donor immune cells attack the patient's body, and this study foc…
Phase: PHASE2 • Sponsor: Mats Remberger • Aim: Disease control
Last updated May 22, 2026 14:04 UTC